Xvivo Perfusion AB
(LTS:0RKL)
kr
471.13141
-2.4818 (-0.52%)
Market Cap: 15.12 Bil
Enterprise Value: 14.69 Bil
PE Ratio: 73.15
PB Ratio: 7.28
GF Score: 89/100 Q2 2020 Xvivo Perfusion AB Earnings Call Transcript
Jul 10, 2020 / 12:00PM GMT
Release Date Price:
kr176
(-3.61%)
Operator
Ladies and gentlemen, welcome to the XVIVO Perfusion Q2 2020 Results Webcast. I will now hand over to Dag Andersson, CEO. Sir, please go ahead.
Dag Andersson;publ;President
Xvivo Perfusion AB;CEO & Director
()- -
Thank you very much. Good afternoon or good morning or good evening, depending on where you are in the world. My name is Dag Andersson, and I'm sitting here in Gothenburg again with Christoffer Rosenblad.
Christoffer Rosenblad;publ;CFO
Xvivo Perfusion AB;Deputy CEO, Deputy MD & Board Secretary
()- -
Good afternoon.
Dag Andersson;publ;President
Xvivo Perfusion AB;CEO & Director
()- -
And I have now been CEO for as long as 6 weeks. And so it's my pleasure actually to present first -- report here to all of you. And just to tell you a little bit about my background, I mean I served for 11 years before joining XVIVO as CEO and
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot